CNS Pharmaceuticals
CNSP
CNS Pharmaceuticals (CNSP) news
Recent news
CNS Pharmaceuticals Inc. raises $22.5M; offering $22.5M: Form D
AInvest Wire · May 19, 2026CNS Pharmaceuticals jumps 15% after achieving completion of planned enrollment in potentially pivotal study of Berubicin for the treatment of glioblastoma multiforme
CNS Pharmaceuticals jumps 15% after achieving completion of planned enrollment in potentially pivotal study of Berubicin for the treatment of glioblastoma multiforme CNS Pharmaceuticals, a biopharmaceutical company, has announced that it has achieved the completion of planned enrollment in a…
AInvest Wire · Jan 17, 2024Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.